NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Drug Shortages, Pricing, and Regulatory Activity

Christopher Stomberg

NBER Working Paper No. 22912
Issued in December 2016
NBER Program(s):HC, HE

This study examines the patterns and causes of shortages in generic non-injectable drugs (e.g., tablets and topicals) in the United States. While shortages for injectable drugs have garnered more attention, shortages of other forms of prescription drugs have also been on the increase. In fact, they follow a strikingly similar trend with a number of important tablet drugs having recently been affected by shortage. This poses important questions about the root causes of these trends since most explanations found in the literature are specific to generic injectable drugs. Using a simple heuristic framework, three contributing factors are explored: regulatory oversight, potential market failures in pricing/reimbursement, and competition. This paper features an empirical examination of the contribution of changes in regulatory oversight to drug shortages. A pooled dynamic regression model using FDA data on inspections and citations reveals a statistically significant relationship between FDA regulatory activity (inspections and citations) and drug shortage rates. This result cuts across both injectable and non-injectable drugs, and could reveal a transition in equilibrium quality that should be transitory in nature, but it should also be interpreted with care given the other factors likely affecting shortage rates.

You may purchase this paper on-line in .pdf format from SSRN.com ($5) for electronic delivery.

Access to NBER Papers

You are eligible for a free download if you are a subscriber, a corporate associate of the NBER, a journalist, an employee of the U.S. federal government with a ".GOV" domain name, or a resident of nearly any developing country or transition economy.

If you usually get free papers at work/university but do not at home, you can either connect to your work VPN or proxy (if any) or elect to have a link to the paper emailed to your work email address below. The email address must be connected to a subscribing college, university, or other subscribing institution. Gmail and other free email addresses will not have access.

E-mail:

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w22912

Forthcoming: Drug Shortages, Pricing, and Regulatory Activity, Christopher Stomberg. in Measuring and Modeling Health Care Costs, Aizcorbe, Baker, Berndt, and Cutler. 2017

Users who downloaded this paper also downloaded* these:
Stomberg Drug Shortages, Pricing, and Regulatory Activity
Lindsey w1760 Taxpayer Behavior and the Distribution of the 1982 Tax Cut
Bullock, Gerber, Hill, and Huber w19080 Partisan Bias in Factual Beliefs about Politics
Stroebel and Vavra w20710 House Prices, Local Demand, and Retail Prices
Gustman, Steinmeier, and Tabatabai w22815 The Affordable Care Act as Retiree Health Insurance: Implications for Retirement and Social Security Claiming
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us